ANALYSIS: The initial dopamine hit of expanding into a new market is often fleeting as reality bites and the realisation of what you bought sets in.
Delano GallagherTue, 24 Sep 2024
The story of Australian company CSL’s path from a government body focused on antivenoms, to the largest plasma provider globally is renowned.
CSL made a series of transformative acquisitions in the early-2000s, first Swiss-based ZLB for US$740 million and then US-based Aventis Behring for US$925m,
Want to read more? It's easy.
Choose your best value subscription option
Individual
Group membership
NBR Marketplace
Yearly Premium Online Subscription
NZ$499.00 / yearly
Monthly Premium Online Subscription
NZ$44.95 / monthly
Smartphone Only Subscription
NZ$24.95 / monthly
Premium Group Membership 10 Users
NZ$350+GST / monthly
$35 per user - Pay by monthly
credit card debit
Premium Group Membership 20 Users
NZ$600+GST / monthly
$30 per user - Pay by monthly
credit card debit
Premium Group Membership 50 Users
NZ$1250+GST / monthly
$25 per user - Pay by monthly
credit card debit
Premium Group Membership 100 Users
NZ$1875+GST / monthly
$18.75 per user - Pay by monthly
credit card debit
